Stocks TelegraphStocks Telegraph
Stock Ideas

UNCY Company Profile and Key Details

NASDAQ : UNCY

Unicycive Therapeutics, Inc.

$0.60
0.0013+0.22%
At Close 4:00 PM
$0.62
0.02+3.33%
After-Market 07:26 PM
64.46
BESG ScoreESG Rating

UNCY Stock Price Chart

Stock Price Today

Unicycive Therapeutics, Inc. (UNCY) stock surged +0.22%, trading at $0.60 on NASDAQ, up from the previous close of $0.60. The stock opened at $0.62, fluctuating between $0.58 and $0.64 in the recent session.

Stock Snapshot

0.6
Prev. Close
0.62
Open
62.41M
Market Cap
103.8M
Number of Shares
0.58
Day Low
0.64
Day High
-1.31
P/E Ratio
84.27%
Free Float in %
-0.46
EPS (TTM)
-0.11
Book Value
-0.53
Cash Flow per Share
767.02K
Volume

Stock Price History Chart

DateOpenHighLowCloseVolume
Feb 04, 20250.620.640.580.60767.02K
Feb 03, 20250.590.630.580.601.13M
Jan 31, 20250.580.640.580.611.43M
Jan 30, 20250.530.580.520.581.05M
Jan 29, 20250.530.540.520.53604K
Jan 28, 20250.580.590.510.541.38M
Jan 27, 20250.590.620.550.57939.03K
Jan 24, 20250.620.630.590.60979.5K
Jan 22, 20250.650.660.620.62620.96K
Jan 21, 20250.630.660.620.65475.23K
Jan 17, 20250.610.650.610.62586.4K
Jan 16, 20250.660.670.610.611.27M
Jan 15, 20250.680.680.630.671.13M
Jan 14, 20250.690.730.650.66851.3K
Jan 13, 20250.650.720.580.691.96M
Jan 10, 20250.740.740.650.661.94M
Jan 08, 20250.780.780.720.741.65M
Jan 07, 20250.760.790.690.782.37M
Jan 06, 20250.780.780.730.761.14M
Jan 03, 20250.820.830.760.78998.11K

Contact Details

Los Altos, CA 94022

United States

Website: https://www.unicycive.comContact: 650 351 4495

About Company

Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Altos, California.

Company Information

Employees14
Beta2.29
Sales or Revenue$675.00K
5Y Sales Change%0%
Fiscal Year EndsDecember
SectorHealthcare
IndustryBiotechnology

Frequently Asked Questions

What is the current Unicycive Therapeutics, Inc. (UNCY) stock price?

Unicycive Therapeutics, Inc. (NASDAQ: UNCY) stock price is $0.60 in the last trading session. During the trading session, UNCY stock reached the peak price of $0.64 while $0.58 was the lowest point it dropped to. The percentage change in UNCY stock occurred in the recent session was 0.22% while the dollar amount for the price change in UNCY stock was $0.00.

UNCY's industry and sector of operation?

The NASDAQ listed UNCY is part of Biotechnology industry that operates in the broader Healthcare sector. Unicycive Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of UNCY?

Mr. Douglas Jermasek M.B.A.
Vice President of Marketing & Strategy
Mr. John W. Townsend CPA
Chief Financial Officer
Dr. Shalabh K. Gupta M.D., MPA
Founder, Chairman, Chief Executive Officer & Pres
Dr. Pramod Gupta Ph.D.
Executive Vice President of Pharmaceutical & Bus. Operations

How UNCY did perform over past 52-week?

UNCY's closing price is 197.67% higher than its 52-week low of $0.20 where as its distance from 52-week high of $1.82 is -66.92%.

How many employees does UNCY have?

Number of UNCY employees currently stands at 14.

Link for UNCY official website?

Official Website of UNCY is: https://www.unicycive.com

How do I contact UNCY?

UNCY could be contacted at phone 650 351 4495 and can also be accessed through its website. UNCY operates from 4300 El Camino Real, Los Altos, CA 94022, United States.

How many shares of UNCY are traded daily?

UNCY stock volume for the day was 767.02K shares. The average number of UNCY shares traded daily for last 3 months was 1.44M.

What is the market cap of UNCY currently?

The market value of UNCY currently stands at $62.41M with its latest stock price at $0.60 and 103.8M of its shares outstanding.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph